SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-21-000471
Filing Date
2021-01-04
Accepted
2021-01-04 20:25:33
Documents
2
Period of Report
2021-01-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm211461d6_3.html 3  
1 OWNERSHIP DOCUMENT tm211461d6_3.xml 3 3231
2 EXHIBIT 24 tm211461d6_ex-24.htm EX-24 8505
  Complete submission text file 0001104659-21-000471.txt   13107
Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Issuer) CIK: 0001657312 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SOLENO THERAPEUTICS INC. 1235 RADIO ROAD, SUITE 110 REDWOOD CITY CA 94065
Business Address
Sinclair Andrew (Reporting) CIK: 0001762451 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38067 | Film No.: 21503605